Pharmacoeconomic aspects of the treatment of diabetic foot syndrome
https://doi.org/10.14341/2072-0351-5686
Abstract
About the Authors
Marina Fedorovna KalashnikovaNadezhda Viktorovna Maksimova
Oleg Viktorovich Udovichenko
Yury Ivanovich Suntsov
References
1. Дедов И.И., Шестакова М.В. Сахарный диабет. Руководство для врачей. - М.: Универсум Паблишинг, 2003.
2. International Consensus on the Diabetic Foot and Practical Guidelines on the Management and the Prevention of the Diabetic Foot // International Working Group on the Diabetic Foot. - 2007. - www.iwgdf.org.
3. Сунцов Ю.И., Дедов И.И., Шестакова М.В. Скрининг осложнений сахарного диабета как метод оценки качества лечебной помощи больным. По результатам 5-летней деятельности научно-практического проекта. - М.: Мобильный Диабет-Центр, 2008.
4. Frykberg R.G. Epidemiology of the diabetic foot: Ulcerations and amputations // Advances in Wound Care. - 1999. - Apr.
5. Katz I.A., Harlan A., Miranda-Palma B., Prieto-Sanchez L., et al. A randomised trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers // Diabetes Care. - 2005. - 28(3). - P. 555-559.
6. Amputations Linked to Diabetes Pierre Lefebvre, president of the International Diabetes Federation, Date: 01 Sep 2005 http:www.hospitalmanagement. net/features/feature627/.
7. Klonoff D.C., Schwartz D.M. An Economic Analysis of Interventions for Diabetes // Diabetes Care. - 2000. - 23. - P. 390-404.
8. Frykberg R.G., Zgonis T., Armstrong D.G., Driver V.R. et al. National Institute for Clinical Excellence Guideline 10 - Type 2 diabetes: prevention and management of foot problems - 2004 // Journal of Foot and Ankle Surgery September. - 2006. - Vol. 45, Issue 5. - P. 1-66.
9. Franks P.J., Gottrup F. Outcomes and Structures of Care: The European Perspective // Wounds. - 2004. - 16(5). - P. 173-182.
10. Анциферов М.Б., Галстян Г.Р., Токмакова А.Ю., Дедов И.И. Синдром нейропатической стопы // Сахарный диабет. - 2001. - № 2.
11. Watkins P.J. Clinical review: The diabetic foot // BMJ. - 2003. - 326. - P. 977-979.
12. Комелягина Е.Ю., Анциферов М.Б. Факторы риска и профилактика синдрома диабетической стопы // РМЖ. - 2003. - том 11, № 27. - С.
13. Постановление Правительства города Москвы от 8 апреля 2008 г. №259-ПП «О Городской целевой среднесрочной программе развития здравоохранения «Столичное здравоохранение» на 2008- 2010 гг.».
14. Багирова В.Л., Колганова Н.А., Раздобарин К.А. Актуальность фармакоэкономических исследований для оптимизации рынка лекарственных препаратов // www.medi.ru, апрель, 2005; том 6. - С. 157. - С. 500-507.
15. Drummond M.F. Economic Evaluation In Health Care // Oxford University Press. 2001.
16. Apelqvist J., Ragnarson -Tennvall G., Larsson J., Persson U. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting // Foot Ankle Int. - 1995. - Jul; 16 (7). - P. 388-394.
17. Apelqvist J., Ragnarson-Tennvall G., Persson U., Larsson J. Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation // J. Intern. Med. - 1994. - may; 235 (5). - P. 463-471.
18. Gottrup F. Organization of wound healing services: The Danish experience and the importance of surgery // Wound Repair Regen. - 2003. - 11. - Р. 452-457.
19. Воробьев П.А., Авксентьева М.В., Юрьев А.С., Сура М.В. Клинико- экономический анализ. - М.: Ньюдиамед, 2004.
20. Joshua A. Ray at all. Review of the Cost of Diabetes Complications // Curr. Med. Res. Opin. - 2005. - 21(10). - P. 1617-1629.
21. Karen Stockl, Ann Vanderplas, Eskinder Tafesse, Eunice Chang Costs of Lower-Extremity Ulcers Among Patients With Diabetes // Diabetes Care. - 2004. - vol. 27 № 9. - P. 2129-2134.
22. Harrington C., Zagari M.J., Corea J., Klitenic J. A cost analysis of diabetic lower-extremity ulcers // Diabetes Care. - 2000. - Sep; 23(9) . - Р. 1333-1338.
23. Franks P.J., Gottrup F. Outcomes and Structures of Care: The European Perspective // Wounds. - 2004. - 16(5). - P. 173-182.
24. Prompers L., Huijberts M., Schaper N., Apelqvist J. et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study // Diabetologia. - 2008. - 51. - Р. 1826-1834.
25. Nash T., Bellew J.W., Cunningham M., McCulloch J. Identifying Cause for Advancement to Amputation in Patients with Diabetes: The Role of Medical Care and Patient Compliance // Wound. - 2005. - 17 (2). - P. 32- 36.
26. Klonoff D.C., Schwartz D.M. An Economic Analysis of Interventions for Diabetes // Diabetes Care. - 2000. - 23. - P. 390-404.
27. Бреговский В.Б. Помощь пациентам с синдромом диабетической стопы в Санкт-Петербурге: проблемы и пути их решения // Сахарный диабет. 2009, № 1.
28. Сунцов Ю.И., Дедов И.И., Болотская Л.Л. Экономический эффект использования современных технологий в лечении сахарного диабета // Сахарный диабет. - 2006. - 2. - C. 60-62.
29. Harrington C., Zagari M.J., Corea J., Klitenic J. A cost Analysis of diabetic lover extremity ulcers // Diabetes Care. - 2000. - vol. 23, № 9. - Р.
30. Green M.F., Aliabadi Z., Green В.T. Diabetic foot: Evaluation and Management // South Med. J. - 2002. - 95(1). - P. 95-101.
31. Frykberg R.G. The team approach in diabetic foot management // Adv. Wound. Care. - 1998. - 11. - P. 71-77.
32. Granick M.S., Ladin D.A. The multidisciplinary in-hospital wound care team: Two models // Adv. Wound. Care. - 1998. - 11. - P. 80-83.
33. Zhang P., Engelgau M.M., Norris S.L., Gregg E.W., Narayan K.M.V. Application of Economic Analysis to Diabetes and Diabetes Care // Annals of Internal Medicine. - 2004. - vol. 140, № 11. - Р. 972-977.
34. Frykberg R.G., Zgonis T., Armstrong D.G. et al. Diabetic foot disordes: A Clinical practice guideline (2006 revision) // The Journal of Foot & Ankle Surgery. 2006; Vol. 45, № 5.
35. Wagner E.N., Sandhu N., Newton K.M. et al. Effect of improved glycemic control on health care costs and utilization // JAMA. - 2001. - 285(2). - P. 182-189.
36. Удовиченко О.В., Галстян Г.Р. Применение иммобилизирующих разгрузочных повязок (методика total contact cast) при лечении синдрома диабетической стопы. Методические рекомендации / Под ред. академика Дедова И.И. - М., 2005.
37. Armstrong D.G., Nguyen H.C., Lavery L.A., Van Schie C.H.M., Boulton A.J.M., Harkless L.B. Off-loading the diabetic foot wound: A randomised clinical trial // Diabetes Care. - 2001. - 24(6) . - Р. 1019-1022.
38. Shearer A., Scuffham P., Gordois A., Oglesby A. Predicted costs and outcomes of reduced vibration detection in the UK // The Diabetic Foot. - 2003. - 6(1). - P. 30-37.
39. Katz I.A., Harlan A., Miranda-Palma B., Prieto-Sanchez L., et al. A randomised trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers // Diabetes Care. - 2005. - 28(3). - P. 555-559.
40. Tennvall R.G., Apelqvist J., Eneroth M. Costs of deep foot infections in patients with diabetes mellitus // Pharmacoeconomics. - 2000. - 18. - P. 225-238.
41. Lipsky B.A., Berendt A.R., Deery H.G. Diagnosis and Treatment of Diabetic Foot Infections. The Infectious Diseases Society of America // Clinical Infectious Diseases. - 2004. - 39. - P. 885-910.
42. Boeri C., Bernard L., Lavigne J.P. et al. Management of diabetic foot infections. Clinical practice guidelines // Mйdecine et maladies infectieuses. - 2007. - 37. - P. 14-25.
43. Brunerovб L., Andĕl M. Calculation of the costs of drugs, medical materials, certain medical procedures and social services for patients with diabetic foot syndrome // Vnitr. Lek. - 2003. - Jun; 49 (6) . - Р. 457-464.
44. Eckman M.H., Greenfield S., Mackey W.C., Wong J.B., Kaplan S., Sullivan L., Dukes K., Pauker S.G. To examine the cost-effectiveness of approaches to the diagnosis and treatment of foot infections and suspected osteomyelitis in patients with type 2 diabetes. Journal of the American Medical Association // JAMA. - 1995. - 273 (9). - P. 712-720.
45. Viennet C., Bride, J., Gabiot A.C., Humbert P. Comparison of different wound dressings on cultured human fibroblasts and collagen lattices // J.Wound. Care. - 2003. - 12:10. - Р. 385-390.
46. Xakellis G.C., Chrischilles E.A. Hydrocolloid versus saline gauze dressing in treating pressure ulcers: A cost-effectiveness analysis // Arch. Phys. Med. Rehab. - 1992. - 73. - Р. 463-466.
47. Jurczak F., Dugrй T., Johnstone A., Offori T., Vujovic Z., Hollander D. Randomised clinical trial of hydrofiber dressing with silver versus povidone- iodine gauze in the management of open surgical and traumatic wounds // International Wound Journal March. - 2007. - Vol. 4. - Issue 1. - Р. 66-76.
48. Meaume S., Teot I., Lasareth I. et al. The importance of pain reduction through dressing selection in routine wound management: the MAPP study // J. Wound. Care. - 2004. - 13. - P. 10409-10413.
49. Mino Y. Necessity of appropriate treatment and care for pressure ulcers from the viewpoint of cost effectiveness // Nurse Plus One [Japanese] . - 1994. - 4(13). - P. 11-14.
50. Mino Y. Cost-effectiveness in care and treatment of pressure ulcers in 21st century. In: Seikei-geka kango (Orthopedic Nursing) // Medica Shuppan. - 2001. - P. 82-85.
51. Fanucci D., Seese J. Multi-faceted use of calcium alginates. A painless, cost-effective alternative for wound care management // Ostomy Wound Management. - 1991. - 37. - P. 16-22.
52. Ohura T., Sanada H., Mino Y.. Clinical Activity-Based Cost Effectiveness of Traditional Versus Modern Wound Management in Patients with Pressure Ulcers.//Wounds. 2004;16 (5). - P. 157-163;
53. Payne W.G., Posnett J., Alvarez O., Brown-Etris M., et al. A Prospective, Randomized Clinical Trial to Assess the Cost-effectiveness of a Modern Foam Dressing vs. a Traditional Saline // Ostomy Wound Management. 2009; V 55 (2);
54. Удовиченко О.В., Галстян Г.Р., Ерошкин И.А., Ефимов А.А., Носов О.В., Васильев Ю.Г. Применение новых технологий в лечении синдрома диабетической стопы: клинический случай // Лечащий врач. - 2003. - № 10.
55. Radack K., Wyderski R.J. Conservative management of intermittent claudication //Ann. Intern. Med. - 1990. - 113. - P. 135-146.
56. Apelqvist J., Sellman A., Katzman P. et al. Hyperbaric Oxygen Therapy as adjunctive treatment of chronic diabetic foot ulcers // 8th scientific meeting of the DFSG (25-28 september 2009, Slovenia).
57. Brothers T.E., Rios G.A., Robison J.G., Elliot B.M. Justification of intervention for limb-threatening ischemia: asurgical decision analysis // Cardiovasc. Surg. - 1999. - 7. - P. 62-69.
58. Panayiotopoulos Y.P., Tyrrell M.R., Arnold F.J., Korzon-Burakowska A., Amiel S.A., Taylor P.R. Results and cost analysis of distal [crural/pedal] arterial revascularisation for limb salvage in diabetic and non-diabetic patients // Diabet. Med. - 1997. - Mar; 14(3) . - Р. 214-20.
59. Gupta S.K., Veith F.J., Ascer E., Flores S.A., Gliedman M.L. Cost factors in limb-threatening ischaemia due to infrainguinal arteriosclerosis // Eur. J. Vasc. Surg. - 1988. - 2. - Р. 151-154.
Review
For citations:
Kalashnikova M.F., Maksimova N.V., Udovichenko O.V., Suntsov Yu.I. Pharmacoeconomic aspects of the treatment of diabetic foot syndrome. Diabetes mellitus. 2010;13(2):113-119. (In Russ.) https://doi.org/10.14341/2072-0351-5686

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).